Preventing Allergic Reactions to Gadolinium-Based Contrast Agents. Review uri icon

Overview

abstract

  • Although the low incidence of immediate-type gadolinium-based contrast agent (GBCA) allergic reactions is widely known, preventing these reactions and properly managing them to reduce their adverse sequel can improve the already exceedingly favorable GBCA safety profile. This review article should help those who order, supervise, or administer GBCA contrast agents, including recognizing and handling allergic reaction risks intrinsic to their use. Areas of focus include factors indicating increased allergic reaction risk, patient selection strategies, skin testing, premedication, and treatment of adverse events.

publication date

  • December 1, 2016

Research

keywords

  • Contrast Media
  • Drug Hypersensitivity
  • Gadolinium
  • Hypersensitivity, Immediate

Identity

Scopus Document Identifier

  • 84991448102

Digital Object Identifier (DOI)

  • 10.1097/RMR.0000000000000106

PubMed ID

  • 27748715

Additional Document Info

volume

  • 25

issue

  • 6